Aequor
Aequor is a technology company.
Financial History
Aequor has raised $200K across 1 funding round.
Frequently Asked Questions
How much funding has Aequor raised?
Aequor has raised $200K in total across 1 funding round.
Aequor is a technology company.
Aequor has raised $200K across 1 funding round.
Aequor has raised $200K in total across 1 funding round.
Aequor has raised $200K in total across 1 funding round.
Aequor's investors include Gaingels, Khosla Ventures, MarsBio, Presight Capital, SOSV, Tuesday Capital.
Aequor Technologies, founded in 1998 and headquartered in Piscataway, New Jersey, is a global IT services and staffing company specializing in life sciences, healthcare, and pharmaceuticals. It provides managed IT solutions, including software testing, business intelligence, application development, cloud services, network security, and end-user support, primarily for pharmaceutical and life sciences firms across research, manufacturing, supply chain, and sales.[1][2][3][4] The company also excels in workforce staffing, placing nurses, therapists, allied professionals, physicians, medical technicians, and tech talent in healthcare facilities, clinical labs, schools, and government entities, with a self-service talent portal enhancing candidate experience.[5][6]
With over 1,500 employees, $365.6 million in revenue, and recognition as one of Inc. 5000's fastest-growing private companies, Aequor serves clients from startups to global corporations, driving efficiency through technology and staffing.[2][3] Its growth includes a 25th anniversary milestone in 2023, fueled by investments in people, infrastructure, and innovation.[3]
Aequor was founded in 1998 in Piscataway, New Jersey, initially focusing on high-value IT consulting and solutions for industries like healthcare, life sciences, manufacturing, and media.[2][3] Co-CEOs Kamalpreet S. Virdi (Chairman, with degrees in Biochemistry from Rutgers and Computer Science from NJIT, plus Columbia Executive Education; awards include Entrepreneur of the Year) and Manmeet Virdi (B.S./M.S. in Computer Engineering from NJIT, Columbia Executive Education; board roles in education) lead the firm, building on 15+ years of life sciences expertise.[1][6]
President Joel Williams joined in 2015 via the acquisition of Therapy Staff, bringing operations leadership from prior roles at Supplemental Healthcare and CareerStaff.[6] Early traction came from end-to-end IT services for pharma value chains, evolving into comprehensive staffing by emphasizing healthcare placements and a talent portal, with pivotal growth via Inc. 5000 listings and SIA awards.[2][3][5][6]
Aequor rides the digital transformation wave in life sciences and healthcare, where pharma firms demand compliant IT for AI-driven drug discovery, LIMS, and supply chains amid regulatory pressures like FDA standards.[1][4] Timing aligns with post-pandemic staffing shortages and cloud adoption, enabling pharma efficiency via integrated IT/staffing—e.g., supporting 6,000+ scientists worldwide.[4]
Market forces like talent scarcity in biotech (nurses, IT specialists) and rising cyber threats favor Aequor's hybrid model, influencing the ecosystem by bridging tech gaps for small firms to giants, fostering innovation in personalized medicine and telehealth.[2][5] Its U.S.-focused growth amid global pharma R&D spend (projected $300B+ annually) positions it as a key enabler.[3]
Aequor is poised for expansion in AI-enhanced pharma IT and healthcare staffing, leveraging its portal for gig economy talent and IT for precision medicine tools. Trends like regulatory digitization (e.g., real-world evidence platforms) and workforce flexibility will propel growth, potentially doubling revenue via acquisitions or international pharma deals.[3][4][6]
Its influence may evolve toward full-spectrum workforce-tech platforms, solidifying leadership in life sciences amid talent wars—echoing its 1998 roots in efficient tech deployment for high-stakes industries.[2][5]
Aequor has raised $200K across 1 funding round. Most recently, it raised $200K Seed in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2023 | $200K Seed | Gaingels, Khosla Ventures, MarsBio, Presight Capital, SOSV, Tuesday Capital |